Hypertension Trial, Recruiting NCT06700044 Sponsor: Region Skane Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06700044
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Pregnant women aged 18 or older
  • Women considered at high risk of preeclampsia (a serious condition involving high blood pressure during pregnancy), meaning they have at least one high-risk factor, or three or more moderate-risk factors, according to Swedish obstetric guidelines
  • Women considered at low risk of preeclampsia, meaning they have no high-risk factors or fewer than three moderate-risk factors
  • High-risk factors include: autoimmune conditions such as lupus or antiphospholipid syndrome; preeclampsia or eclampsia in a previous pregnancy; a previous pregnancy with high blood pressure and complications such as early preterm birth, poor fetal growth, fetal death, or placental abruption; Type 1 or Type 2 diabetes; twin or triplet pregnancy; kidney disease; long-term high blood pressure; or IVF pregnancy using a donor egg
  • Moderate-risk factors include: first-time pregnancy; a mother, maternal grandmother, or sister who had preeclampsia; BMI over 30; age over 40; a gap of more than 10 years between pregnancies; blood pressure above certain levels at the first antenatal visit; African descent; or diagnosed obstructive sleep apnea
  • People who are able to read, understand, and sign a written consent form

Who may not be able to join:

  • People already taking part in another clinical study
  • People who have used probiotic supplements in the two weeks before the study starts, or who plan to use them during the study
  • People who have taken antibiotics in the six weeks before the study starts
  • People currently taking metformin, progesterone, or any regular medication that might affect the study results (such as laxatives)
  • People with a weakened immune system
  • People with Type 1 or Type 2 diabetes
  • People with inflammatory bowel disease
  • People with coeliac disease
  • People with a history described as "bad obstetric history" (confirm with trial site for the exact definition)
  • People with other serious health conditions that might affect gut bacteria or their ability to participate in the study
  • People who may have difficulty understanding the study information or consent process due to language or other barriers

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +46 70 6024476

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Region Skane
Registry
ClinicalTrials.gov
Start date
10 December 2024
Est. completion
1 December 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Changes in oral and gut microbiota composition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov